Historical shareholding details of TRIDENT CHEMPHAR LIMITED holdings in Aurobindo Pharma Ltd. (AUROPHARMA)

Quarterly changes of TRIDENT CHEMPHAR LIMITED shareholding in Aurobindo Pharma Ltd. over the previous quarters

Quarter Name Total no. shares held Percent Holding Pledged Locked
shares % shares %
Dec 2024 Trident Chemphar Limited 782,241 0.13% 0 0.00% 0 0.00%
Dec 2024 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,572,131 2.85% 0 0.00% 0 0.00%
Sep 2024 Trident Chemphar Limited 782,241 0.13% 0 0.00% 0 0.00%
Sep 2024 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,572,131 2.85% 0 0.00% 0 0.00%
Jun 2024 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Jun 2024 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Mar 2024 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Mar 2024 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Dec 2023 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Dec 2023 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Sep 2023 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Sep 2023 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Jun 2023 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Jun 2023 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Mar 2023 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Mar 2023 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Dec 2022 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Dec 2022 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,750,000 22.42% 0 0.00%
Sep 2022 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Sep 2022 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,750,000 22.42% 0 0.00%
Jun 2022 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Jun 2022 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,750,000 22.42% 0 0.00%
Mar 2022 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Mar 2022 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,750,000 22.42% 0 0.00%
Dec 2021 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Dec 2021 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 6,856,000 40.99% 0 0.00%
Sep 2021 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Sep 2021 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 6,970,000 41.67% 0 0.00%
Jun 2021 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Jun 2021 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 110,000 0.66% 0 0.00%
Mar 2021 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Mar 2021 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,710,000 22.18% 0 0.00%
Dec 2020 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Dec 2020 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 10,000 0.06% 0 0.00%
Sep 2020 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Sep 2020 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,100,000 18.53% 0 0.00%
Jun 2020 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Jun 2020 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,100,000 18.53% 0 0.00%
Mar 2020 Trident Chemphar Limited 789,537 0.13% 0 0.00% 0 0.00%
Mar 2020 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,100,000 18.53% 0 0.00%
Dec 2019 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,100,000 18.53% 0 0.00%
Sep 2019 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,100,000 18.53% 0 0.00%
Jun 2019 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,100,000 18.53% 0 0.00%
Mar 2019 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,726,716 2.85% 3,100,000 18.53% 0 0.00%
Sep 2018 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Jun 2018 Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Mar 2018 Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,426,716 2.80% 0 0.00% 0 0.00%
Mar 2018 Trident Chemphar Ltd 300,000 0.05% 0 0.00% 0 0.00%
Dec 2017 Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd. (Jointly Holding) 16,426,716 2.80% 0 0.00% 0 0.00%
Dec 2017 Trident Chemphar Ltd 300,000 0.05% 0 0.00% 0 0.00%
Jun 2017 Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Mar 2017 Axis Clinicals Limited Trident Chemphar Limited Rpr Sons Advisors Pvt.Ltd (Jointly Holding) 16,726,716 2.85% 0 0.00% 0 0.00%
Dec 2016 Trident Chemphar Limited 12,147,226 2.08% - 0.00% - -%
Sep 2016 Trident Chemphar Limited 12,147,226 2.08% - 0.00% - -%
Jun 2016 Trident Chemphar Limited 12,147,226 2.08% - 0.00% - -%
Mar 2016 Trident Chemphar Limited 12,147,226 2.08% 400,000 3.29% - -%

View all shareholdings details of Aurobindo Pharma Ltd.